# Reduced PCV Dosing Schedules in South African Infants

> **NCT02943902** · PHASE3 · COMPLETED · sponsor: **University of Witwatersrand, South Africa** · enrollment: 600 (actual)

## Conditions studied

- Pneumonia
- Meningitis

## Interventions

- **BIOLOGICAL:** Pneumococcal conjugate vaccine (PCV10 ) 1+1, 6 weeks
- **BIOLOGICAL:** Pneumococcal conjugate vaccine (PCV10 ) 1+1, 14 weeks
- **BIOLOGICAL:** Pneumococcal conjugate vaccine (PCV10 ) 2+1
- **BIOLOGICAL:** Pneumococcal conjugate vaccine (PCV13 ) 1+1, 6 weeks
- **BIOLOGICAL:** Pneumococcal conjugate vaccine (PCV13 ) 1+1, 14 weeks
- **BIOLOGICAL:** Pneumococcal conjugate vaccine (PCV13 ) 2+1

## Key facts

- **NCT ID:** NCT02943902
- **Lead sponsor:** University of Witwatersrand, South Africa
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01-09
- **Primary completion:** 2019-02-26
- **Final completion:** 2019-02-26
- **Target enrollment:** 600 (ACTUAL)
- **Last updated:** 2019-12-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02943902

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02943902, "Reduced PCV Dosing Schedules in South African Infants". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02943902. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*